Filter by: patients
What is Ipratropium?

Ipratropium is an anticholinergic drug with similar effects to atropine, but since it is poorly absorbed into the blood, it has few side effects (such as tachycardia) at therapeutic doses. It is available as an inhalant or a nasal spray. It is also used for the reduction of secretions in the lungs.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
COPD (Chronic Obstructive Pulmonary Disease) 23 1 Efficacy_major
Asthma 13 3 Efficacy_major Efficacy_moderate
Other 5 2 Efficacy_major
Asthma 4 0
Runny nose (rhinorrhea) 4 1 Efficacy_moderate
Emphysema 4 1 Efficacy_moderate

See all 53 patients currently taking Ipratropium

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
1
Mild
2
None
6

Commonly reported side effects, conditions, and hospitalizations associated with Ipratropium

Dry mouth (xerostomia) 1
Shakiness 1
Sinus headaches 1
Bad taste in mouth 1

Reported Dosages

Frequently reported dosages based on patients currently taking Ipratropium. See all 29 dosages

  0.02% as needed 0.018 mg daily 0.02 g daily 0.036 mg daily 0.06 g daily 0.08 g daily 2 other daily 17 mcg daily 34 mcg daily 80 mcg daily
  6 Number of Patients: 6 7 Number of Patients: 7 4 Number of Patients: 4 4 Number of Patients: 4 4 Number of Patients: 4 2 Number of Patients: 2 2 Number of Patients: 2 2 Number of Patients: 2 4 Number of Patients: 4 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Ipratropium (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 4   Doctor's advice: 36%
Course of treatment ended 3   Course of treatment ended: 27%
Side effects too severe 2   Side effects too severe: 18%
Did not seem to work 1   Did not seem to work: 9%
Other 1   Other: 9%

See all 11 patients who’ve stopped taking Ipratropium

Currently Taking Ipratropium

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Ipratropium

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Ipratropium

Always
6 67%
Usually
1 11%
Sometimes
2 22%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Ipratropium

Very
1 11%
Somewhat
3 33%
A little
1 11%
Not at all
4 44%

Cost

Paid out of pocket

Cost of Ipratropium

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
5 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.